The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
104006624 10400662 4 F 2012 20160629 20140821 20160707 EXP US-ASTRAZENECA-2014SE03102 ASTRAZENECA 61.00 YR F Y 45.40000 KG 20160707 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
104006624 10400662 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MICROGRAMS, 2 PUFFS TWO TIMES A DAY Y U 21929 BID
104006624 10400662 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MICROGRAMS, 2 PUFFS TWO TIMES A DAY Y U 21929 BID
104006624 10400662 3 C PROAIR HFA ALBUTEROL SULFATE 1 Respiratory (inhalation) 8.5 GM 2 PUFFS Q4 HRS PRN 0
104006624 10400662 4 C PROAIR HFA ALBUTEROL SULFATE 1 Respiratory (inhalation) 8.5 GM 2 PUFFS Q4 HRS PRN 0
104006624 10400662 5 C PROAIR HFA ALBUTEROL SULFATE 1 Respiratory (inhalation) ALBUTEROL 0
104006624 10400662 6 C PROAIR HFA ALBUTEROL SULFATE 1 Respiratory (inhalation) ALBUTEROL 0
104006624 10400662 7 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 0 1 DF QD
104006624 10400662 8 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 0 1 DF QD
104006624 10400662 9 C AZELAZTINE HCL 2 0
104006624 10400662 10 C FORTE 2 0
104006624 10400662 11 C ALLERGY MEDICATION DIPHENHYDRAMINE HYDROCHLORIDE 1 0
104006624 10400662 12 C BLOOD PRESSURE PILL UNSPECIFIED INGREDIENT 1 0
104006624 10400662 13 C SLEEPING PILL 2 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
104006624 10400662 1 Lung disorder
104006624 10400662 2 Chronic obstructive pulmonary disease
104006624 10400662 3 Lung disorder
104006624 10400662 4 Chronic obstructive pulmonary disease
104006624 10400662 5 Lung disorder
104006624 10400662 6 Chronic obstructive pulmonary disease
104006624 10400662 7 Lung disorder
104006624 10400662 8 Chronic obstructive pulmonary disease
104006624 10400662 9 Hypersensitivity

Outcome of event

Event ID CASEID OUTC COD
104006624 10400662 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
104006624 10400662 Bone disorder
104006624 10400662 Cardio-respiratory arrest
104006624 10400662 Cough
104006624 10400662 Hypersensitivity
104006624 10400662 Malaise
104006624 10400662 Off label use
104006624 10400662 Oral candidiasis
104006624 10400662 Product use issue
104006624 10400662 Sinusitis
104006624 10400662 Somnolence
104006624 10400662 Tongue coated

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
104006624 10400662 1 2012 0
104006624 10400662 2 2012 0
104006624 10400662 3 2012 0
104006624 10400662 4 2012 0
104006624 10400662 7 2012 0
104006624 10400662 8 2012 0